B Cells Join the Physiology of Exercise: Immune cells best known for fighting infection may also help power exercise. In a new mouse study, researchers found that animals with depleted B cells performed worse on endurance and strength tests than control mice, whether the B-cell loss was genetic or induced by antibody treatment. The team then traced the effect to metabolism. Mice lacking B cells showed lower post-exercise glutamate levels in muscle, a change linked to poorer mitochondrial function and weaker skeletal-muscle performance. The proposed mechanism is that B cells produce TGF-β1, a protein that helps the liver generate glutamate, which then supports working muscle. The finding suggests B cells may act as a previously unrecognized bridge between the immune system and exercise physiology. Still, outside experts caution that exercise performance is complex and that the pathway now needs validation in humans. (Nature)

Iceland’s Mosquitoes Signal a Bigger Arctic Blind Spot: The arrival of mosquitoes in Iceland, once the only Arctic nation without them, is being framed as more than a quirky ecological milestone. It signals a broader failure to systematically monitor Arctic arthropods, a hugely diverse group that includes insects and spiders and plays vital roles in pollination, nutrient cycling, food webs, and population control. Because arthropods respond quickly to environmental shifts, they are both indicators and drivers of climate-linked change. The stakes are high: mismatches between insects and shorebird breeding, heavier insect harassment of caribou and reindeer, and herbivore outbreaks that reshape tundra can all cascade into deeper ecological disruption, including permafrost thaw. With warming, tourism, shipping, and infrastructure accelerating species movement, the piece argues that the Arctic urgently needs coordinated, international arthropod monitoring grounded in Indigenous knowledge. (Science)

Genomes Point to the Biology of Hyperemesis Gravidarum: One of the week’s stronger human-genetics papers tackles a condition that is common in mild form but potentially life-threatening at its worst: hyperemesis gravidarum. In a multi-ancestry genome-wide association study covering 10,974 cases and 461,461 controls, researchers identified ten associated loci, including previously implicated signals such as GDF15 and several additional loci including SLITRK1, SYN3, IGSF11, FSHB, TCF7L2, and CDH9. The study also reports that some signals appear to act through maternal tissues, while others may involve fetal genotype, and it links several loci to pregnancy weight gain, duration, birth weight, and pre-eclampsia. The big takeaway is that severe pregnancy nausea is looking more like a tractable biological problem tied to appetite, insulin signaling, and placental biology, not a vague clinical mystery. (Nature)

A New Atlas Connects DNA Sequence to Methylation Across Tissues: A major epigenetics paper this week lays out a cross-species framework for how inherited sequence differences shape DNA methylation patterns over development. Using mouse and human methylation and genetic-variation data, the authors identify thousands of differentially methylated regions linked to sequence polymorphisms that disrupt transcription-factor binding. In mice, they argue that these regions are programmed during two major windows, implantation and organogenesis. In humans, they map 33,574 regions where common SNPs control allele-specific methylation across more than 200 whole-genome bisulfite-sequencing samples from 39 purified cell types. Many of those regions overlap enhancers, silencers, expression QTLs, and disease-associated variants. This matters because it offers a mechanistic bridge from non-coding DNA sequence to regulatory behavior, and gives researchers a new atlas for interpreting disease-linked variants that do not alter proteins directly. (Nature)

Illumina’s Two-Color Chemistry Comes Under Fresh Scrutiny: A new Genome Biology paper is the sort of methods story that can quietly ripple across a lot of downstream science. The authors examine a recurrent sequencing artifact associated with Illumina’s two-color fluorescent dye chemistry, used in NovaSeq instruments, and ask how it affects somatic variant detection. Their point is not that the platform is unusable, but that newer high-throughput chemistry can introduce systematic biases that matter when researchers are trying to call mutations precisely, especially in cancer. Because sequencing pipelines are often treated as neutral measurement tools, papers like this are a reminder that instrumentation choices can shape biological conclusions. For genetics, cancer genomics, and diagnostics alike, that makes this more than a technical footnote: it is a quality-control story about what mutations are real, which ones are artifacts, and how confidently labs should interpret low-frequency findings. (Springer)

Structural Variants Emerge as a Key Engine of Prostate Cancer Resistance: Metastatic castration-resistant prostate cancer remains lethal largely because tumors keep evolving around targeted therapy. A new Genome Biology study focuses on that evolution at the structural-variant level, reconstructing complex structural variant profiles in 193 tumors using whole-genome and transcriptome sequencing, with matched Hi-C data for a large subset. The background is important: amplification of the androgen receptor locus is already known as a major resistance mechanism, and prior work has implicated extra-chromosomal DNA in that process. This study pushes further, asking whether extra-chromosomal DNA and other complex structural variants also reshape additional resistance drivers over time. The broader implication is that therapy resistance is not just a story of point mutations or simple copy-number gains, but of large-scale genome architecture changing in convergent, clinically meaningful ways across tumors exposed to treatment pressure. (Springer)

CRISPR Organoids Help Untangle Ovarian Cancer’s Mutation Combinations: A new Genetics paper uses multiplex CRISPR mutagenesis in mouse fallopian-tube organoids to probe one of cancer genomics’ hardest questions: which mutation combinations actually drive disease behavior, rather than merely appearing alongside it. Working across 20 candidate high-grade serous ovarian carcinoma driver genes, the researchers report that, beyond Trp53, mutations in Nf1, Cdkn2a, and Map2k4 were especially prevalent in transformed organoids. They also found that different mutations tracked with different pathological phenotypes after transplantation into mice, with Map2k4 mutants tending toward papillary-glandular tumors and Nf1 mutants toward more mesenchymal-like states. On the treatment side, Map2k4 mutant cells showed particular sensitivity to paclitaxel, and ROCK inhibition increased trametinib sensitivity in both Map2k4- and Nf1-mutant organoids. It is a strong example of functional genomics moving from gene lists toward experimentally testable therapeutic logic. (OUP Academic)

Wolbachia Timelines Get Recalibrated, With Biocontrol Implications: Not every important genetics story this week was about humans. A new Genetics paper revisits the evolutionary timing of Wolbachia, the maternally inherited bacterial endosymbionts that are already central to mosquito-borne disease control strategies. Using new calibrations based on filarial nematodes whose Wolbachia lineages codiverge with their hosts, the authors argue that some earlier timelines for host switching and incompatibility-locus evolution were too short. They report that “wMel-like” Wolbachia lineages largely evolve through bifurcation over 1–2 million years rather than constant gene exchange with distant strains, and they suggest previous estimates for the spread of “wRi-like” variants were underestimated by roughly sevenfold. That may sound niche, but it is directly relevant to how researchers think about the stability, evolution, and long-term deployment of Wolbachia-based biocontrol programs aimed at curbing pathogen transmission in insects. (OUP Academic)

A Maize Gene Offers a More Mechanistic Route to Drought Tolerance: Plant genetics also produced a notable applied story this week. In PLOS Genetics, researchers report that ZmSKIP, a maize SKI-interacting protein, enhances drought tolerance by promoting stomatal closure and reducing water loss. Mechanistically, the paper ties that effect to transcriptional suppression of ZmBAG8 and to phosphorylation of ZmSKIP by ZmSnRK2.3 at specific serine residues under drought stress. The proposed model is appealing because it links signaling, transcriptional control, and a clear physiological readout: stomatal aperture. In practical terms, drought tolerance remains one of the most valuable targets in crop genetics, and studies like this are important precisely because they move beyond broad stress associations to a defined pathway that might be engineered or selected for. It is early-stage crop biology, but the logic is concrete and agriculturally relevant. (PLOS)

Replication Stress in the Embryo Shows Up as Placental Failure: Another PLOS Genetics paper from the week connects genome maintenance machinery to pregnancy biology in a direct way. The researchers show that persistent replication stress caused by mutations in the MCM2–7 replicative helicase disrupts placentation and reduces embryo viability in mice. Importantly, the embryos themselves appeared morphologically normal, but their placentae showed a drastically diminished junctional zone, pointing to a developmental bottleneck outside the embryo proper. That framing matters. It suggests that some poor pregnancy outcomes may arise not just from classical embryonic defects, but from failures in how proliferating placental lineages cope with replication stress and genomic instability. For developmental genetics, this is a sharp reminder that fetal survival depends on extraembryonic tissues with their own vulnerabilities. For medical readers, it adds mechanistic depth to the broader category of placental dysfunction. (PLOS)

Bacteria May Be Making DNA in a Way Biology Textbooks Did Not Expect: Among the week’s most conceptually striking stories, Science reported on a newly described bacterial defense system that appears to synthesize DNA without using a nucleic-acid template in the usual way. The article frames the finding as a challenge to the familiar textbook picture in which DNA is copied from DNA and information flows according to standard central-dogma logic. The system emerges from bacterial antiviral defense, an arena that has already yielded CRISPR and other transformative tools, so the discovery is attracting attention not only for what it says about basic biology, but for what it may eventually enable as a biotechnology platform. Even before applications arrive, the news value here is high: it suggests life has evolved at least one more route to making DNA than researchers had fully appreciated. That is the kind of finding that can reset assumptions across molecular biology. (Science)

FusioMR Pushes Causal-Gene Mapping Beyond One-Exposure-One-Outcome Simplicity: From the American Journal of Human Genetics comes a methodological advance aimed at a very live problem in statistical genetics: how to map causal genes from molecular QTL data when the instrumental variables are limited and the biology is networked rather than tidy. The paper introduces FusioMR, described as a set of Mendelian-randomization models that can estimate causal effects for molecular or complex-trait exposures on one or more outcomes. That multi-outcome framing is important because many traits share pathways and many loci act pleiotropically, so single-exposure, single-outcome approaches can miss the architecture researchers actually care about. This is not the splashiest story in clinical terms, but it is exactly the kind of tool paper that can shape later discoveries by giving analysts a sturdier way to move from association to plausible causation in genomics datasets. (Cell)